Add-on Acquisition • Life Science

Amryt Pharma Acquires SomPharmaceuticals S.A

On February 22, 2016, Amryt Pharma acquired life science company SomPharmaceuticals S.A for 30M GBP

Acquisition Context

This is Amryt Pharma’s 2nd transaction in the Life Science sector.
This is Amryt Pharma’s 0th largest (disclosed) transaction.
This is Amryt Pharma’s 1st transaction in Switzerland.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	February 22, 2016
Target	SomPharmaceuticals S.A
Sector	Life Science
Buyer(s)	Amryt Pharma
Deal Type	Add-on Acquisition
Deal Value	30M GBP

Target Company

SomPharmaceuticals S.A

Épalinges, Switzerland

SomPharmaceuticals S.A is a biopharmaceutical company focused on developing novel somatostatin analogue ("SSA") peptide medicines for patients with rare neuroendocrine diseases with high unmet need.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Amryt Pharma

Dublin, Ireland

Category	Company
Sector	Life Science
Employees	182
Revenue	182M GBP (2020)

DESCRIPTION

Amryt Pharma is a pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt Pharma is based in Dublin, Ireland.

Deal Context for Buyer	#
Overall	2 of 4
Sector: Life Science	2 of 4
Type: Add-on Acquisition	2 of 4
Country: Switzerland	1 of 1
Year: 2016	2 of 2

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2016-02-22	Birken AG Niefern-Oschelbronn, Germany Birken AG is a pharmaceutical development and manufacturing company.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2016-02-22

Birken AG

Niefern-Oschelbronn, Germany

Birken AG is a pharmaceutical development and manufacturing company.

Buy

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2019-05-21	Aegerion Pharmaceuticals Cambridge, Massachusetts, United States Aegerion Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of pharmaceutical products to treat cardiovascular and metabolic diseases. Aegerion Pharmaceuticals, Inc. was formed in 2005 and is headquartered in Cambridge, Massachusetts.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2019-05-21

Aegerion Pharmaceuticals

Cambridge, Massachusetts, United States

Aegerion Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of pharmaceutical products to treat cardiovascular and metabolic diseases. Aegerion Pharmaceuticals, Inc. was formed in 2005 and is headquartered in Cambridge, Massachusetts.

Buy

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Switzerland M&A - 2016 M&A